Focus on health, energy, and sustainability
Epidemiological studies and early clinical data suggest that GLP-1 receptor agonists may reduce the risk of neurodegenerative diseases including Alzheimer disease, Parkinson disease, and other forms of dementia
[57] You L, Deng Y, Li D, Lin Y, Wang Y
Whrend GIP und GLP-1 primr die Insulinsekretion modulieren und das Sttigungsgefhl zentralnervs steuern, erffnet die zustzliche Aktivierung des Glucagon-Rezeptors einen vllig neuen metabolischen Signalweg
Glucagon signals the brain from the gut through the vagal nerve, making us feel full
GLP-1s promote weight loss in several ways: Appetite suppression : GLP-1s act on the parts of the brain that control your appetite (satiety centers), reducing hunger and even thoughts and cravings for food Slowed stomach emptying : By keeping food in your stomach longer, GLP-1s make you feel full for a longer period after you eat Improved insulin function : GLP-1s help reduce the insulin spikes that promote storing fat and lead to increased appetite What Happens When You Stop a GLP-1
